Literature DB >> 1096799

Antibiotic resistance patterns of clinical isolates of Serratia marcescens.

R C Cooksey, E R Bannister, W E Farrar.   

Abstract

Antimicrobial susceptibility patterns of 102 clinical isolates of Serratia marcescens from three medical centers were studied by using disk sensitivity and agar dilution methods. The least resistance was demonstrated against gentamicin, nalidixic acid, chloramphenicol, and sulfisoxazole, all of which inhibited more than 80% of the strains. Cephalothin was completely ineffective, and more than 90% of strains were resistant to ampicillin and tetracycline. As demonstrated by the agar dilution method, the minimal inhibitory concentration of nalidixic acid, gentamicin, tobramycin, and chloramphenicol for most strains fell within therapeutically attainable concentrations. The prevalence of resistance to ampicillin, cephalothin, and tetracycline was nearly the same at all three medical centers, whereas there appeared to be patterns characteristic for each center with regard to the other drugs used. Eleven of the isolates produced pigment and exhibited patterns similar but not identical to those of the nonpigmented strains, all 11 being resistant to between three and six drugs. Half of the strains were resistant to five or more antibiotics, indicating that some Serratia exhibit resistance to an unusually broad range of therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1096799      PMCID: PMC429151          DOI: 10.1128/AAC.7.4.396

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  The Klebsiella-Enterobacter (Aerobacter)-Serratia group. A clinical and bacteriological evaluation.

Authors:  E B Edmondson; J P Sanford
Journal:  Medicine (Baltimore)       Date:  1967-07       Impact factor: 1.889

2.  Antibiograms and lipid contents of pigmented and nonpigmented strains of Serratia marcescens.

Authors:  M A Miller; C Y Chang; J C Tsang
Journal:  Antimicrob Agents Chemother       Date:  1973-07       Impact factor: 5.191

3.  Evaluation of non-lactose-fermenting members of the Klebsiella-Enterobacter-Serratia division. II. Antibiotic susceptibility.

Authors:  T R Oberhofer; R Hajkowski
Journal:  Am J Clin Pathol       Date:  1970-11       Impact factor: 2.493

4.  Serratia marcescens septicemia.

Authors:  W H Dodson
Journal:  Arch Intern Med       Date:  1968-02

5.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

6.  Relation of cell wall lipid content of Serratia marcescens to resistance to antimicrobial agents.

Authors:  E B Winshell; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

7.  Specific distribution of R factors in Serratia marcescens strains isolated from hospital infections.

Authors:  S Schaefler; J Winter; A Catelli; J Greene; B Toharski
Journal:  Appl Microbiol       Date:  1971-09

8.  Lipid content of antibiotic-resistant and -sensitive strains of Serratia marcescens.

Authors:  C Y Chang; R E Molar; J C Tsang
Journal:  Appl Microbiol       Date:  1972-12

9.  Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.

Authors:  J N Wilfert; F F Barrett; W H Ewing; M Finland; E H Kass
Journal:  Appl Microbiol       Date:  1970-02

10.  Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens.

Authors:  P Greenup; D J Blazevic
Journal:  Appl Microbiol       Date:  1971-09
  10 in total
  10 in total

1.  Requirement for Serratia marcescens cytolysin in a murine model of hemorrhagic pneumonia.

Authors:  Norberto González-Juarbe; Chris A Mares; Cecilia A Hinojosa; Jorge L Medina; Angelene Cantwell; Peter H Dube; Carlos J Orihuela; Molly A Bergman
Journal:  Infect Immun       Date:  2014-11-24       Impact factor: 3.441

2.  Hospital isolates of Serratia marcescens transferring ampicillin, carbenicillin, and gentamicin resistance to other gram-negative bacteria including Pseudomonas aeruginosa.

Authors:  V M Olexy; T J Bird; H G Grieble; S K Farrand
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

3.  Outbreak of nosocomial urinary tract infections caused by Serratia marcescens.

Authors:  T Okuda; N Endo; Y Osada; H Zen-Yoji
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

4.  Resistance plasmid transfer by Serratia marcescens in urine.

Authors:  D R Schaberg; A K Highsmith; I K Wachsmuth
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

5.  R factor-mediated antibiotic resistance in Serratia marcescens.

Authors:  R C Cooksey; G M Thorne; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

6.  Gentamicin use and Pseudomonas and Serratia resistance: effect of a surgical prophylaxis regimen.

Authors:  N J Roberts; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

7.  Marvelous but Morbid: Infective endocarditis due to Serratia marcescens.

Authors:  Varun K Phadke; Jesse T Jacob
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2016-05

8.  Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.

Authors:  S M Markowitz; D J Sibilla
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

9.  Antimicrobial susceptibility of clinical isolates of Serratia marcescens.

Authors:  J S Alvarez; B Regueiro; M J Garrido
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

10.  Genome Sequence of Serratia plymuthica V4.

Authors:  S Cleto; G Van der Auwera; C Almeida; M J Vieira; H Vlamakis; R Kolter
Journal:  Genome Announc       Date:  2014-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.